AR115565A1 - FUSION PROTEINS INCLUDING PROGRANULIN - Google Patents

FUSION PROTEINS INCLUDING PROGRANULIN

Info

Publication number
AR115565A1
AR115565A1 ARP190101673A ARP190101673A AR115565A1 AR 115565 A1 AR115565 A1 AR 115565A1 AR P190101673 A ARP190101673 A AR P190101673A AR P190101673 A ARP190101673 A AR P190101673A AR 115565 A1 AR115565 A1 AR 115565A1
Authority
AR
Argentina
Prior art keywords
progranulin
fusion proteins
proteins including
proteins
ftd
Prior art date
Application number
ARP190101673A
Other languages
Spanish (es)
Inventor
Lengerich Bettina Van
Ankita Srivastava
Kathryn M Monroe
Todd P Logan
Paolo Gilbert Di
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of AR115565A1 publication Critical patent/AR115565A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan en la presente proteínas de fusión que comprenden progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)).Provided herein are fusion proteins comprising progranulin and an Fc polypeptide. Also provided herein are methods for the use of such proteins for the treatment of progranulin-associated disorders (eg, a neurodegenerative disease, such as frontotemporal dementia (FTD)).

ARP190101673A 2018-06-18 2019-06-18 FUSION PROTEINS INCLUDING PROGRANULIN AR115565A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862686579P 2018-06-18 2018-06-18

Publications (1)

Publication Number Publication Date
AR115565A1 true AR115565A1 (en) 2021-02-03

Family

ID=74672489

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190101673A AR115565A1 (en) 2018-06-18 2019-06-18 FUSION PROTEINS INCLUDING PROGRANULIN

Country Status (1)

Country Link
AR (1) AR115565A1 (en)

Similar Documents

Publication Publication Date Title
ECSP20081591A (en) FUSION PROTEINS INCLUDING PROGRANULIN
PE20230036A1 (en) PROGRANULIN VARIANTS
CL2022000036A1 (en) Modified polypeptides and uses thereof (divisional application no. 201900261)
CY1124309T1 (en) MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF
DOP2019000241A (en) ANTI-PEPTIDE BETA AMYLOID N3pGlu ANTIBODIES AND THEIR USES
MX2020006322A (en) Engineered il-2 fc fusion proteins.
CL2017001584A1 (en) Antibiostatin antibodies, polypeptides containing variant fc regions, and methods of use
CY1122644T1 (en) TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, PHARMACEUTICAL FORMS AND THEIR USE
CR20190480A (en) Use of klk5 antagonists for treatment of a disease
WO2018115432A3 (en) Compounds for the treatment of bovine or swine respiratory disease
MX2020007628A (en) Compositions and methods of use.
PH12020500054A1 (en) Novel therapeutic enzyme fusion protein and use thereof
CL2022001712A1 (en) Progranulin variants
CL2019003167A1 (en) Anti-jagged1 antigen-binding proteins.
BR112018071586A2 (en) use of thyroid beta-agonists
CL2019002155A1 (en) Factor ix fusion proteins and procedures for their preparation and use.
AR115565A1 (en) FUSION PROTEINS INCLUDING PROGRANULIN
ECSP22019177A (en) NKG2D FUSION PROTEINS AND THEIR USES
BR112018071123A2 (en) (+) - azasetron for use in treating ear disorders
MX2022014899A (en) Lfa3 variants and compositions and uses thereof.
EA202190062A1 (en) FUSION PROTEINS CONTAINING PROGRANULIN
AR119984A1 (en) NKG2D FUSION PROTEINS AND THEIR USES
TH72941B (en) Devices for the delivery of artificial implants and methods of using them